Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants

Suh-Fang Jeng1, Chyong-Hsin Hsu, Po-Nien Tsao

  • 1School of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan.

Insights

Bronchopulmonary dysplasia (BPD) in very-low-birthweight infants is linked to poorer developmental and clinical outcomes. Severe BPD significantly predicts these adverse effects throughout infancy.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Developmental Pediatrics

Background:

  • Very-low-birthweight (VLBW) infants are at high risk for respiratory complications.
  • Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in VLBW infants.
  • The impact of BPD on long-term neurodevelopmental and clinical outcomes requires further investigation.

Purpose of the Study:

  • To examine developmental and clinical outcomes in VLBW infants with and without BPD.
  • To assess if BPD severity predicts poor developmental outcomes beyond other risk factors.
  • To correlate BPD classification with infant outcomes.

Main Methods:

  • 103 VLBW infants (< or =1500g) were enrolled.
  • BPD severity was graded using the NIH consensus definition.
  • Neurodevelopment was assessed using the Neonatal Neurobehavioral Examination and Bayley Scales of Infant Development.
  • Clinical outcomes included rehospitalization and pulmonary medication use.

Main Results:

  • Infants with BPD showed higher rates of clinical morbidity compared to those without BPD.
  • Severe BPD was associated with increased incidences of developmental delay throughout infancy.
  • BPD significantly predicted poor 1-year developmental and clinical outcomes in VLBW infants.

Conclusions:

  • BPD is a significant predictor of adverse developmental and clinical outcomes in VLBW infants.
  • The severity of BPD, as defined by the NIH consensus, correlates with these poor outcomes.
  • Early identification and management of BPD are crucial for improving long-term outcomes in VLBW infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History